Figure 5.
Analysis of disease progression according to longitudinal CombiFlow analysis. (A) Gating of the main compartments according to CD45 expression and side scatter area (SSC-A) for the merged FCS files from Patient 3. CD45– cells are gated out. (B) tSNE landscape colored by condition for all included samples (left) or per sample (right). (C) Expression of included markers per condition with the MRD-specific clusters separated to identify the subpopulation most likely to have caused relapse. (D) Expression of CD13 and CD97 on the tSNE landscape per sample. FSC-A, forward scatter area.